Literature DB >> 11152309

Improved microbiological techniques using the polymerase chain reaction and pulsed-field gel electrophoresis for diagnosis and follow-up of enterohaemorrhagic Escherichia coli infection.

C Welinder-Olsson1, E Kjellin, M Badenfors, B Kaijser.   

Abstract

The aims of the present investigation were to evaluate the microbiological diagnostic procedures, especially polymerase chain reaction (PCR) versus culture and seroagglutination, in relation to the clinical features of enterohaemorrhagic Escherichia coli (EHEC) infection and to study the status of EHEC in the western part of Sweden. During 1997 and 1998, stool specimens from 3,948 patients were analysed by PCR for the presence of EHEC with verotoxin (VT)1- and/or VT2-producing DNA sequences. The stool specimens were also cultured for Escherichia coli O157:H7, Salmonella, Campylobacter, Shigella and Yersinia. Fifty-five patients were positive by PCR. Thirty-nine patients were positive for EHEC by PCR and culture. Of these, 29 were infected with EHEC serogroup O157:H7 strains. All EHEC isolates were analysed by pulsed-field gel electrophoresis (PFGE); 17 different clones were identified. Studies on the duration of the presence of EHEC in the gut showed that EHEC often disappears rather quickly, i.e. within 2 weeks. In one patient, however, EHEC remained for several months. In conclusion, PCR, rather than culture and agglutination, should be the method of choice for microbiological diagnosis of EHEC infection. PCR is more sensitive than culture for detecting EHEC in the gut.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11152309     DOI: 10.1007/s100960000380

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  7 in total

1.  Genetic typing of shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis.

Authors:  Liesbet De Baets; Imme Van der Taelen; Marina De Filette; Denis Piérard; Lesley Allison; Henri De Greve; Jean-Pierre Hernalsteens; Hein Imberechts
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

2.  Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota.

Authors:  Nahid Karami; Forough Nowrouzian; Ingegerd Adlerberth; Agnes E Wold
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Genetic profiling of enterohemorrhagic Escherichia coli strains in relation to clonality and clinical signs of infection.

Authors:  Christina Welinder-Olsson; Maria Badenfors; Tom Cheasty; Eva Kjellin; Bertil Kaijser
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Environmental factors influencing human viral pathogens and their potential indicator organisms in the blue mussel, Mytilus edulis: the first Scandinavian report.

Authors:  Bodil E Hernroth; Ann-Christine Conden-Hansson; Ann-Sofi Rehnstam-Holm; Rosina Girones; Annika K Allard
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

5.  Sub-typing of extended-spectrum-β-lactamase-producing isolates from a nosocomial outbreak: application of a 10-loci generic Escherichia coli multi-locus variable number tandem repeat analysis.

Authors:  Nahid Karami; Lisa Helldal; Christina Welinder-Olsson; Christina Ahrén; Edward R B Moore
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

6.  Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden.

Authors:  Lisa Helldal; Nahid Karami; Christina Welinder-Olsson; Edward R B Moore; Christina Åhren
Journal:  BMC Microbiol       Date:  2017-01-06       Impact factor: 3.605

7.  Scandinavium goeteborgense gen. nov., sp. nov., a New Member of the Family Enterobacteriaceae Isolated From a Wound Infection, Carries a Novel Quinolone Resistance Gene Variant.

Authors:  Nachiket P Marathe; Francisco Salvà-Serra; Roger Karlsson; D G Joakim Larsson; Edward R B Moore; Liselott Svensson-Stadler; Hedvig E Jakobsson
Journal:  Front Microbiol       Date:  2019-11-05       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.